GlassScriptPhysician profile
Shervin Molayem
NPI 1407183205
$10,431.66
in general payments reported to CMS, 2019-2025
9 companies · $120 in 2025
The $120 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,147 · 2020: $5,025 · 2021: $26.53 · 2022: $17.92 · 2023: $45.71 · 2024: $50.02 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $10,014.67 | 2019-2023 | Nobelactive |
| Dentsply Sirona INC | $111.66 | 2022-2025 | Cerec, Waveone Gold Conform Fit, Cerec Tessera |
| Ace Surgical Supply Co., INC. | $97.41 | 2019 | |
| Straumann USA LLC | $69.37 | 2024-2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $65.93 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $21.67 | 2019 | |
| American Orthodontics Corporation | $20.00 | 2025 | Master Series, Empower-Metal, Radiance |
| Solventum Corporation | $17.68 | 2025 | Clarity Aligners, 3m Scotchbond, Filtek |
| Geistlich Pharma, North America, INC. | $13.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shervin Molayem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.